DEVELOPMENT AND VALIDATION OF ISOCRATIC STABILITY INDICATING REVERSE PHASE LC METHOD WITH PDA DETECTION FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE IN ITS MARKETED FORMULATION
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2015, Vol 7, Issue 3
Abstract
A simple and precise stability indicating RP-HPLC method was developed and validated for simultaneous determination of Olmesartan Medoxomil (OLM) and Hydrochlorothiazide (HCTZ) in pure drug and Pharmaceutical marketed formulation. Chromatography was carried out on Inertsil ODS C18 (150 × 4.6 mm, 5m particle size) column in an isocratic mode with mobile phase containing 0.2 % acetate buffer and acetonitrile in the ratio of 60:40% v/v at a flow rate of 1.0 ml/min. The analyte was monitored using PDA detector at 252 nm. The retention time was found to be 5.080 min and 10.493 min for Hydrochlorothiazide (HCTZ) and Olmesartan Medoxomil (OLM) respectively. The proposed method was found to be having linearity in the concentration range of 20-120µg/ml for Olmesartan Medoxomil (OLM) and 12.5-75.0µg/ml for Hydrochlorothiazide (HCTZ) with correlation coefficient value of 0.999 respectively. The mean % recoveries obtained were found to be 99.86-100.02 % for Hydrochlorothiazide (HCTZ) and 99.92-100.16 % for Olmesartan Medoxomil (OLM) respectively. Stress testing which covered acid, base, peroxide, UV light, neutral and thermal degradation was performed on under test to prove the specificity of the method and the degradation was achieved. The developed method has been statistically validated according to ICH guide lines. Thus the proposed method can be successfully applied for the stability indicating simultaneous determination of Olmesartan Medoxomil (OLM) and Hydrochlorothiazide (HCTZ) in bulk and combined tablet dosage form and in routine quality control analysis.
Authors and Affiliations
Mohammad Yunoos, D. Gowri Sankar
DEVELOPMENT AND VALIDATION OF A HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) METHOD FOR DETERMINATION OF FIPRONIL AND PYRIPROXYFEN IN A VETERINARY PHARMACEUTICAL PRODUCT
In the present study, an analytical HPLC method was developed for the estimation of Fipronil, Pyriproxyfen, Benzyl alcohol, Butylhydroxyanisole (BHA) and Butylhydroxytoluene (BHT) and related substances from a veterinary...
COMPATIBILITY STUDIES OF ATORVASTATIN CALCIUM WITH SELECTED EXCIPIENTS BY MEANS OF THERMAL AND FT-IR SPECTROSCOPIC METHODS FOR THE DEVELOPMENT OF IMMEDIATE RELEASE TABLET
The objectives of present investigation is to evaluate the compatibility of Atorvastatin calcium with immediate release excipients and to optimize the tablet which release is best comparable with innovator product by var...
Formulation and Characterization of Ondansetron Hydrochloride Matrix Tablets for Sustained Drug Delivery
The objective of proposed work was to develop Ondansetron Hydrochloride (OND HCl) sustained release matrix tablets for the better treatment of vomiting for extended period of time. Sustained release matrix tablet is the...
The Impact of Physicochemical Characteristics on Therapeutic Efficacy of Anticancer Nanomaterials: A Review
Cancer is a leading cause of death throughout the world which suffers from treatment failures mainly due to intensive toxicity and lack of effectiveness of conventional drugs. The application of nanotechnology in cancer...
AMELIORATIVE EFFECT OF EUGENOL AND ANETHOLE ON ARSENIC INDUCED OXIDATIVE DNA DAMAGE IN CULTURED HUMAN PERIPHERAL BLOOD LYMPHOCYTES
Arsenic contamination is one of the major health concerns all over the world and associated with various types of cancer and pathological effects. The production of reactive oxygen species (ROS) plays a crucial role in a...